All News

pregnant-776506__180.jpg

PIANO Study - Safety of Biologics in Pregnancy

d Jack Cush, MD

The results of the long awaited PIANO study have been reported in the journal Gastroenterology, showing that pregnant women with IBD may safely receive biologic or thiopurine therapy throughout the pregnancy without substantial added risk to the unborn or mother.

Read Article
cost.healthcare.jpg

Colchicine Approval Took a Huge Toll on CMS

d

Colchicine, the old gout drug often cited as a cheap anti-inflammatory, hasn't been such a good deal since FDA approval, a study in JAMA Internal Medicine showed.

Read Article
Telemedicine.MD.Computer.phone (keep)

How are RA patients doing using telemedicine/virtual care?

d Janet Pope, MD, MPH, FRCPC

Rheumatologists switched their practices overnight from primarily in person to nearly all virtual care as COVID-19 pandemic geared up in March 2020 and then to a blend of in person and virtual care. How are RA patients doing?

Read Article
(if this is true) Shame on @expressScripts and forcing money driven biologic changes (from secukinumab to ixekizumab) upon patients and doctors. This is soooo wrong! https://t.co/DYKSItCbYL

Links:

Dr. John Cush RheumNow ( View Tweet)

#BestACR20Tweets RT @DrMiniDey : Study on #telehealth in #rheumatology patients in the US finds those with #comorbidities and high disease activity are most likely to take up remote consults. Abs#1962 #ACR20 @RheumNow https://t.co/8USU39mTPk https://t.co/ioT1b1x4IO

Links:

Dr. John Cush RheumNow ( View Tweet)
Pipeline Therapies for Urate Lowering: Dr. Michael Pillinger #ACR20 https://t.co/M3ahjjZWK8 https://t.co/Ipc0nowK2t

Links:

Dr. John Cush RheumNow ( View Tweet)
Check out Dr. Kathyrn Dao's blog experience. A rheumatology researcher signs up for the COVID-19 vaccine! https://t.co/B9Wsvo7DJH

Links:

Dr. John Cush RheumNow ( View Tweet)

#BestACR20Tweets RT @MeralElRamahiMD :Conditional recommendation to add bDMARD or tsDMARD in RA pts on maximally tolerated dose of MTX over adding HCQ+SSZ (triple therapy) per draft recommendation of new ACR RA treatment guidelines. #ACR20 @ElaineHusniMD https://t.co/tCAbgYi3h0 https://t.co/AoEOJd3pQh

Links:

Dr. John Cush RheumNow ( View Tweet)
How COVID Changed Work: Drs. Rachel Tate, Cassie Calabrese and Mary Hinojos Mamut #ACR20 https://t.co/jyM8NPicZF https://t.co/6zA7Kmgzwi

Links:

Dr. John Cush RheumNow ( View Tweet)
Measuring Disease Activity in Psoriatic Arthritis: Dr. Eric Ruderman ( @JointMD) looks at several abstracts that focus on disease activity measurement in psoriatic arthritis presented at the #ACR20 meeting. https://t.co/Tu58NDbc51 https://t.co/RGwON4gu7w

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recs for RA: Treatment recommendations for Hepatitis B - highest risk is for RTX for reactivation! @RheumNow. https://t.co/JvYm9Ii6PV https://t.co/qjXBuzUug6

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR has released 2 free powerpoint slide decks featuring select RA and SLE abstracts from #ACR20 (a 3rd late-breaking slide deck is yet to come!). Download here>> https://t.co/CiNH0xfs7J

Links:

Dr. John Cush RheumNow ( View Tweet)

Cytokine Storm | NEJM https://t.co/sNNKtdPYw8 #cyokinestorm #inflammasomopathy nice review underlying a number of our “auto inflammatory “ funny seronegs with gut rash and other odd features?

Links:

Peter Nash drpnash ( View Tweet)

#BestACR20Tweets RT @ejdein1 : Draft #ACR20 Rx Recs for RA: MTX is conditionally recommended with NORMAL LFTs and no advanced fibrosis. Role of HCQ for NALFD has been suggested at ACR, but not enough for mod-high disease activity @RheumNow. https://t.co/XswkhT1f66 https://t.co/bdngrnY9hc

Links:

Dr. John Cush RheumNow ( View Tweet)
Revisit #ACR20 with our RheumNow podcast. https://t.co/ondNw0G6Pu https://t.co/nauqdGp8fR

Links:

Dr. John Cush RheumNow ( View Tweet)
Worth the read! My Experience as a COVID19 Vaccine Trial Participant by Dr. Kathryn Dao ( @KDAO2011) https://t.co/ILfXLUL8IZ https://t.co/7parTGPllu

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @MeralElRamahiMD : Switching or adding a DMARD in pts w/ mod-high dz RA activity ; hx of previous serious infection w/in the past 12 mos as opposed to starting/increasing GCs is conditionally recommended per draft recs of new ACR RA treatment guidelines.

Dr. John Cush RheumNow ( View Tweet)

Prothrombotic Antiphospholipid Antibodies in COVID-19: Dr. David Liew ( @drdavidliew) abstract #0429 at the #ACR20. https://t.co/5xjThWuLa6 https://t.co/Aezlfqle06

Links:

Dr. John Cush RheumNow ( View Tweet)
New Treatments in Axial Spondyloarthritis: Dr. Antoni Chan ( @synovialjoints) discuses two abstracts presented at the #ACR20 annual meeting. https://t.co/bh7l6C8p7P https://t.co/RN60iWCmet

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @RichardPAConway :Dr Cid presents phase 2 trial of anti-GM-CSF agent mavrilimumab in combination with steroids in GCA. 70 patients. Sustained remission at week 26 in 83.2% of mavrilimumab vs 49.9% of placebo p=0.0038. @DrPujaMehta1 #ACR20 Abstr#L06 https://t.co/ynWbguXXzR
Dr. John Cush RheumNow ( View Tweet)
×